X

    XWELL Inc. (XWEL)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $0.92
    -0.09 (-8.99%)

    Market Cap: $8.68M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    43%(10/23)
    Avg Surprise
    -163.64%
    Streak
    3 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$-0.26N/AN/ABeat+82.0%
    Mar 26
    		$-1.51N/AN/ABeat-53.3%
    Sep 25
    		$-0.26N/AN/ABeat+45.5%
    Jun 25
    		$-0.56N/AN/ABeat+64.3%
    Mar 25
    		$-1.44N/AN/ABeat-87.5%
    Sep 24
    		$-0.99N/AN/ABeat+28.1%
    Jun 24
    		$-0.48N/AN/ABeat+63.3%
    Mar 24
    		$-1.57$0.00N/ABeat-1862.5%
    Sep 23
    		$-0.77$-0.80+3.75%Beat+40.8%
    Jun 23
    		$-1.37$-1.40+2.14%Beat+18.0%
    Mar 23
    		$-1.30$-2.60+50.00%Beat-62.5%
    Dec 22
    		$-0.08$-0.05-60.00%Miss-366.7%
    Sep 22
    		$-1.30$-1.40+7.14%Beat-230.0%
    Jun 22
    		$-1.67$-2.00+16.50%Beat-108.7%
    Mar 22
    		$-0.80$-1.20+33.33%Beat-300.0%
    Dec 21
    		$0.03$0.06-50.00%Miss+113.6%
    Sep 21
    		$1.00$-0.80+225.00%Beat+1100.0%
    Jun 21
    		$-0.80$-0.60-33.33%Miss+46.3%
    Mar 21
    		$-0.20N/A+80.00%Beat+96.1%
    Dec 20
    		$-0.22$-0.07-214.29%Miss+60.0%
    Sep 20
    		$-0.10N/AN/ABeat+98.0%
    Jun 20
    		$-1.49N/AN/ABeat+84.6%
    Mar 20
    		$-5.07N/AN/ABeat-5.0%
    Dec 19
    		$-0.55N/A+60.71%Beat+99.0%
    Sep 19
    		$-5.04$-1.40-260.00%Miss+95.7%
    Jun 19
    		$-9.66$-1.40-590.00%Miss+91.1%
    Mar 19
    		$-4.83$-2.00-141.50%Miss+97.2%
    Dec 18
    		$-52.77$-2.20-2298.64%Miss-109.4%
    Sep 18
    		$-116.16$-144.00+19.33%Beat+49.1%
    Jun 18
    		$-108.12$-84.00-28.71%Miss+67.8%
    Mar 18
    		$-170.04$-96.00-77.13%Miss-733.5%
    Dec 17
    		$-25.20$-6.00-320.00%Miss-82.6%
    Sep 17
    		$-228.00$-132.00-72.73%Miss-1017.7%
    Jun 17
    		$-336.00$-156.00-115.38%Miss-
    Mar 17
    		$-20.40N/AN/ABeat-
    Dec 16
    		$-13.80N/AN/ABeat-
    Sep 16
    		$-20.40N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.35EV/EBITDA0.47x
    Price/FCF-0.58xFCF Yield-172.73%
    Profitability
    Profit Margin-82.90%Operating Margin-26.10%
    ROE-361.40%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage54.04x
    Current Ratio2.27xQuick Ratio2.21x
    Trading Statistics
    Beta1.01Avg Volume39.63K
    52-Week High$2.2052-Week Low$0.26

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.98
    SMA 20$0.99
    SMA 50$1.02
    SMA 200$0.97
    EMA 10$0.98
    EMA 20$0.99
    EMA 50$1.04
    EMA 200$1.04

    MACD

    Line: -0.02Signal: -0.02Hist: 0.00

    ADX

    ADX: 16.9+DI: 22.7-DI: 18.3

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down68.0
    PSAR$1.17

    Bollinger Bands

    Upper Band$1.08
    Lower Band$0.90
    %B Position1736%(Upper)
    Band Width0.08

    RSI (14-Day)

    Neutral
    41.4

    Momentum Oscillators

    Stoch %K33.9
    Stoch %D41.3
    Williams %R-84.5
    ROC (10d)-1.2%
    Momentum-0.01
    CCI (20d)-104.6
    MFI (14d)61.4

    Volatility Measures

    ATR (14d)$0.08(8.8%)
    StdDev (20d)0.04
    Hist Vol79.6%(High)

    Volume Flow

    VWAP$0.94
    OBV489.6M
    AD Line-8.2M
    CMF (20d)-0.189

    Volume Metrics

    Avg Vol (20d)40.1K
    Vol Ratio1.6x(High)
    VWMA (20d)$0.99

    Pivot Points

    R3$1.10
    R2$1.07
    R1$1.04
    Pivot Point$1.01
    S1$0.98
    S2$0.95
    S3$0.92

    Advanced Oscillators

    TSI-7.24
    Ultimate Osc38.8
    KST-49.69

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$7.14M$6.64M$7.15M$7.34M$7.69M$7.02M$7.47M$8.42M$9.28M$8.73M$7.40M$7.47M
    Cost of Revenue$4.20M$4.29M$4.23M$5.85M$5.91M$5.70M$6.35M$6.37M$6.20M$6.05M$6.53M$6.38M
    Gross Profit$2.95M$2.35M$2.92M$1.49M$1.77M$1.32M$1.12M$2.05M$3.08M$2.67M$878,000$1.09M
    Operating Expenses$5.05M$7.77M$11.97M$2.26M$4.47M$4.48M$8.78M$6.82M$4.97M$5.05M$5.98M$13.18M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$4.65M$7.59M$5.86M$1.55M$4.28M$4.31M$4.77M$6.42M$4.72M$4.17M$687,000$3.00M
    Operating Income$-2,104,000$-5,414,000$-9,050,000$-770,000$-2,692,000$-3,158,000$-7,666,000$-4,769,000$-1,893,000$-2,379,000$-5,105,000$-12,089,000
    Interest Income$188,000$-22,000$-23,000$31,000$58,000$-5,000$63,000$106,000$52,000$135,000$0$0
    Interest Expense$-11,000$43,000$34,000$-490,000$-147,000$-58,000$-73,000$-100,000$-97,000$-110,000$155,000$-105,000
    Income Before Tax$-1,832,000$-11,012,000$-9,262,000$-209,000$-2,018,000$-4,588,000$-7,587,000$-4,705,000$-1,791,000$-2,358,000$-4,895,000$-11,591,000
    Income Tax Expense$51,000$0$0$2,000$34,000$0$0$0$0$0$0$0
    Net Income$-1,883,000$-11,012,000$-9,255,000$-211,000$-2,052,000$-4,588,000$-7,636,000$-4,705,000$-1,791,000$-2,358,000$-4,930,000$-11,591,000
    EBITDA$-1,795,000$-10,690,000$-8,718,000$-282,000$-1,792,000$-4,229,000$-7,083,000$-4,335,000$-1,394,000$-2,092,000$-4,841,000$-10,749,000
    EBIT$-2,031,000$-10,947,000$-9,205,000$-730,000$-2,223,000$-4,641,000$-7,723,000$-4,911,000$-1,940,000$-2,603,000$-5,454,000$-11,696,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XWEL

    Government Contracts

    Gov Obligations (TTM)
    $18.14M
    Gov Obligations / Revenue
    62.9%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    5.1 mo

    Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75D30126C21193Department of Health and Human ServicesCenters for Disease Control and Prevention$18.14MJul 6, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Xwell Q2 FY26 revenue falls 7% to $7.15 million; general and administrative expenses rise to $4.65 million

    Xwell reported a 7% decrease in Q2 FY26 revenue, totaling $7.15 million, while general and administrative expenses increased by 8.64% to $4.65 million due to legal costs related to a July 2026 purchase agreement. Despite the revenue drop, gross profit rose to $2.95 million as cost of sales fell significantly. The company plans to sell XpresSpa and XpresTest to focus on non-airport wellness, with the sale expected to close in Q4 2026.

    Bitget•8/15/26•
    Bearish

    XWELL Inc | 10-Q: Q2 2026 Earnings Report

    This document is the Q2 2026 Earnings Report (10-Q filing) for XWELL Inc. It provides detailed financial statements and other mandatory disclosures for the second fiscal quarter of 2026, as required by the Securities and Exchange Commission. The report gives investors and analysts a comprehensive overview of the company's financial performance and position during that period.

    Moomoo•8/14/26•
    Neutral

    XWELL Inc | SCHEDULE 13G/A: Others

    This article states that XWELL Inc. has filed a SCHEDULE 13G/A document with the SEC. A Schedule 13G/A is an amendment to a Schedule 13G, which is an abbreviated statement of beneficial ownership filed by passive investors. The document is titled "Others."

    Moomoo•8/14/26•
    Neutral

    XWELL (XWEL) holders Iroquois Capital and insiders report 0% ownership in 13G/A

    Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page have filed an amended Schedule 13G for XWELL, Inc. (XWEL), indicating they no longer beneficially own any shares of the company's common stock. Each reporting person now reports 0 shares beneficially owned, representing 0% of the outstanding common stock. This filing is based on 8,444,266 shares of XWEL common stock outstanding as of May 14, 2026.

    Stock Titan•8/12/26•
    Somewhat-Bearish

    XWELL Inc (XWEL) Stock News Today

    This article provides current stock information for XWELL Inc (XWEL), including its stock price, market capitalization, and a note that more news will be coming soon. It also lists various financial and analytical sections related to the company's stock performance. The content is primarily a placeholder for future news and analysis.

    TradingKey•8/8/26•
    Somewhat-Bearish

    Frequently Asked Questions About XWEL

    Does XWEL pay dividends?
    XWELL Inc. (XWEL) does not currently pay a regular dividend.
    What is XWEL's market cap?
    XWELL Inc. (XWEL) has a market capitalization of $8.68M with a current stock price of $0.92.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In